PPD Earns American Heart Association’s Fit-Friendly Worksite Designation

Recognized for helping employees achieve and maintain healthy lifestyles

25 Apr. 2013


WILMINGTON, N.C., (April 25, 2013) The American Heart Association has named Pharmaceutical Product Development, LLC (PPD) a gold-level Fit-Friendly Worksite for 2013 as an employer that excels in promoting healthy employee lifestyles. The Fit-Friendly program recognizes employers that champion employees’ wellness and work to create a culture of physical activity and health in the workplace by implementing activities outlined by the association.

“We believe our employees’ health is extremely important and we want to help them protect it,” said Ed Murray, senior vice president, human resources for PPD. “Our wellness culture encourages and helps enable employees to take ownership of their health and strive to become better health care consumers. By focusing on the physical, occupational and intellectual aspects of our employees’ health, including exercise, good nutrition and disease prevention, we endeavor to engage our employees in fun and proven programs to encourage living a healthy lifestyle.”

According to the American Heart Association, a lack of physical activity raises the risk for a host of medical problems, such as heart disease, obesity, high blood pressure and diabetes. To help address such health concerns, PPD provides programs, campaigns and services to educate and empower employees about their health and wellness, including on-site fitness centers or health club reimbursements; group exercise programs; walking courses; healthy eating classes; tobacco free workplaces; and health and wellness awards.

In addition to employee-focused wellness services, the company sponsors the PPD Beach2Battleship Triathlon held each fall in Wilmington, N.C. The PPD Beach2Battleship Triathlon has been ranked among the top five iron distance triathlons in the world by Triathlete magazine. In 2012, more than 2,000 athletes from 45 U.S. states and 10 other nations participated, including dozens of PPD employees and their family members.

Lee Kennedy
+1 919 456 5350

Luke Heagle
+1 910 558 7585

About PPD
PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 12,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.

Except for historical information, all of the statements, expectations and assumptions, including statements, expectations and assumptions about PPD’s Fit-Friendly Worksite designation, contained in this news release are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based and could cause actual results to differ materially from the forward-looking statements. Other important factors that could cause future results to differ materially include the following: the ability to attract, integrate and retain key personnel; competition in the outsourcing industry; compliance with drug development regulations; changes in the regulation of the drug development process; overall global economic conditions; economic conditions, research and development spending, and outsourcing trends in the pharmaceutical, biotechnology and government-sponsored research sectors; consolidation in the pharmaceutical and biotechnology industries; PPD’s ability to win new business; loss, delay or modification of large contracts; higher-than-expected cancellation rates; the rate of conversion of backlog into revenue; actual operating performance; risks associated with and dependence on strategic relationships; risks associated with acquisitions and investments; the ability to control SG&A spending; and rapid technological advances that make our services less competitive. PPD assumes no obligation and expressly disclaims any duty to update these forward-looking statements in the future, except as required by applicable law. These forward-looking statements should not be relied upon as representing PPD’s estimates or views as of any date subsequent to the date hereof.

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
Tel: +1 919 456 4425

Holly Devine Manager, Corporate Communications
Tel: +1 919 456 6389

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.